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Background: Inadequacy of dialysis is one of the main causes of death in hemodialysis patients.  Some studies have suggested that high-
flux membrane improves removal of moderatemolecules while other studies  no significant on them.
Objectives: The aim of this study was to investigate the dialysis adequacy of low-flux versus high-flux membranes in Hemodialysis Patients.
Patients and Methods: Forty hemodialysis patients participated in this cross-over clinical trial. Two sessions of lux and lux membrane 
dialysis were performed  in the first and second stage of the trial. In both stages blood samples before and  dialysis were taken and sent 
to laboratory for assessment. Blood urea nitrogen (BUN), KT/V (K = dialyzer clearance of urea, t = dialysis time, V = volume of distribution 
of urea) and the urea reduction ratio (URR) indexes used to determine dialysis adequacy. Data were analyzed by using SPSS16 and test and 
pair test.
Results: The mean of KT/V was 1.27 ± 0.28 in lux and 1.10 ± 0.32 in membrane which, differences statistically significant (P = 0.017). The mean 
of URR was 0.65 ± 0.09 in and 0.61 ± 0.14 in lux membrane which differences not statistically significant (P = 0.221).
Conclusions: The High-Flux membrane had better dialysis adequacy, so we suggest the use of High-Flux membrane in Hemodialysis 
centers.
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1. Background
Chronic Renal Failure (CRF) is a serious disorder. Four 
hundred thousand people are suffering from CRF in the 
United States of America. Its universal incidence is reck-
oned to be 260 people every year with an increase rate of 
(1). These people will need hemodialysis, peritoneal dialy-
sis or kidney transplant to continue their lives (2). There 
were 12500 patients under hemodialysis in Iran in 2006 
(3). In spite of drastic advances in medical technology, the 
mortality rate of these patients has shown no meaning-
ful decrease during 20 years and has been stabilized at 
18% annually (4).
The principle of hemodialysis involves the clearance 
of solutes across a semipermeable membrane through 
diffusion and ultrafiltration mechanisms. The utilized 
membranes are classified into two main groups: lux 
which is based on using dialyzers with low permeability 
for water (5); and lux non-celluloses membrane with in-
creased which is capable moderatemolecules between 
10000 to 15000 Dalton, including many of the inflam-
matory proteins, ßmicroglobulin and lipoproteins (6). 
Some studies have suggested that high-flux membrane 
improves removal of moderatemolecules such as lipid 
profiles or homocysteine (7, 8) while other studies have 
concluded it has no significant impact on molecules such 
as homocysteine levels (9).
 incomplete removal of uremic toxins, 90% of hemodi-
alysis patients reveal symptoms of pathologic amyloido-
sis caused by after five years of dialysis (10). One of the 
most influential reasons to continue a certain treatment 
is the degree of its impact on the targeted disease; while, 
the inadequacy of dialysis has been recognized as a major 
reason for the mortality rate of the hemodialysis patients 
(11). If the efficiency of hemodialysis is not adequate, the 
level of blood toxins and the clinical symptoms of the pa-
tient are not controlled which lead to either an increase 
in the duration of each dialysis session or the of neces-
sary dialysis per week. This will consequently increase 
the mortality and morbidity of patients, and the cost of 
dialysis (12, 13).
There are a number of factors which influence the ad-
equacy of the dialysis, such as the time of dialysis, the 
dialysate flow rate, the surface of dialyzer and the blood 
flow rate. However, the employments of many of these 
factors are considered impossible, because they are bene-
ficial feasible. For example, increasing the duration of the 
dialysis over four hours is beyond the patient's tolerance 
and will increase the of dialysis to a large extent. Further-
more, increasing the dialysate flow rate do not have a sig-
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nificant effect on the adequacy of the dialysis (14).
With regard to the available capacity of dialysis center 
across the country and the increasing need for further 
facilities, it is to limit the amount and time of dialysis 
to a optimal level. Therefore, reaching to certain level of 
dialysis adequacy is crucial and it has led researchers to 
projects to obtain this adequacy. In spite of the empha-
sis on the employment of -permeable membrane in the 
available research literature (15) and according to the 
crucial importance of using these membranes and the 
emphasis of the National Kidney Association of Iran on 
the necessity of these permeable membranes (16), there 
are still many wards utilizing -permeable membrane 
(17). The contradictory results of current published data 
prompted us to design this clinical trial study.
2. Objectives
This study was performed to compare the efficiency 
of - -lux membranes in patients who referred to dialysis 
center of the Shahid Beheshti Hospital in Hamadan city, 
to investigate the proper membrane in order to increase 
the adequacy of dialysis and increase the level of health 
among these patients.
3. Patients and Methods
This research is a cross-over clinical trial study. Sample 
size was calculated based on a previous study in which 
House et al. (18) have studied the effect of high-flux vs. 
low-flux hemodialysis on homocysteine and lipids. Then 
21 patients was estimated to be needed in each group 
based on the following parameters (β=0.20, α=0.05, σ1 
(variance of homocysteine in high-flux group) = 1.925, 
σ2 (variance of homocysteine in low-flux group) =1.675, 
µ1 - µ2 (mean pre-dialysis homocysteine in high-flux 
group minus mean pre-dialysis homocysteine in low-flux 
group) = 2 (18). However, 40 patients were selected for 
more accuracy From 114 patients who assessed for eligi-
bility, 74 patients excluded because of not having the in-
clusion criteria (n = 32), occurrence of exclusion criteria 
(n = 22) or declined to participate (n = 20).
Inclusion criteria were: participants' age to 60 years, di-
alysis treatment for at least 6 months with conventional 
HD, using fistula or graft as vascular access, at least twice 
4-hour dialysis session per week, consciousness for par-
ticipation in study, hemoglobin ≥ 9 mg/dL, interdialytic 
weigh gain less than 3 kg, no any neoplasia.
Exclusion criteria were: hypotension (systolic BP ≤ 
90mmg), acute clinical conditions (myocardial infarc-
tion, congestive heart failure, stroke, recent surgery, or 
severe sepsis) during the study, any vascular access dys-
function, discontinuation of dialysis less than 4 hours, 
reduction in consciousness, restlessness and agitation, 
severe nausea and vomiting during dialysis, starting oth-
er treatments.
During the research, the dialyzer was fixed and 500 mL/
min bicarbonate solution as dialysate. The blood flow 
rate was fixed for each patient. units of heparin per ses-
sion as anticoagulant were used. The sodium density of 
dialysate was 135−145 meq/L with a stabilized tempera-
ture at 37. The amount of food and liquid taken for each 
participant throughout the study were the same and 
controlled. No blood transfusion was given to any patient 
during the study period.
3.1. Interventions and Comparison
In the first stage all participants underwent dialysis two 
sessions per week in accordance with the guidelines of 
adequacy and efficiency of dialysis (16) by utilizing -mem-
brane (FR5 made by the Soha Co., Iran); then, they at-
tended another two sessions of dialysis in the following 
week by utilizing the −membrane (FR50, made by Soha 
Co., Iran).
The members of the second group were treated similar-
ly except that they attended the dialysis with the utiliza-
tion of -followed by the -membrane based on the guide-
lines of the adequacy and efficiency of dialysis provided 
(19). Blood samples were taken in the second dialysis ses-
sion of each stagethe first sample was taken in the onset 
of dialysis from the arterial line (before dialysis sample) 
and the second sample was taken from the arterial line at 
the end of the dialysis session after 2 minutes decreasing 
the blood flow rate to 80 mL/min (after dialysis sample). 
The samples were labeled and sent to the laboratory to 
determine the level of BUN. The lab technician was not in-
formed about the study groups. The lab process and the 
technicianin-charge for all samples were the same.
he (URR) and the KT/V were utilized. In KT/V measure, K 
stands for the dialyzer clearance (mL/min), T stands for 
the time of dialysis (min), and V, the bottom part of the 
fraction, is the distribution of urea which is equal to to-
tal body water (19). To determine the adequacy of the he-
modialysis based on the KT/V, the Daugirdas formula was 
used (SPkt/v = -(R-0.008×t) + (4+3.5R) UF). In this formula 
stands for the natural logarithm, R is equal to the ratio of 
blood urea nitrogen pre- and post-dialysis. UF is the ultra-
filtration per liter and T is the time of dialysis per hour. 
URR is estimated based on this formula: URR = (urea pre-
dialysisurea post-dialysis)/urea pre-dialysis x100 (20-22).
Data were collected by a questionnaire for demograph-
ic data (age, gender, interdialytic weight gain, kind of 
vascular access, dialysis history, etc.) and a checklist to 
record the BUN before and after dialysis, dialysis session 
time, blood flow rate, dialysate flow rate and the ultrafil-
tration rate. 
3.2. Ethical Considerations
The Research Council and the Human Research Ethics 
Committee of Hamadan University of Medical Sciences 
approved the study protocol and its ethical consider-
ations (D/P/16/35/9/794). To begin the study, the research-
er explained the study process to the patients and they 
Oshvandi k et al.
3Nurs Midwifery Stud. 2014;3(3):e21764
signed a written informed consent. The patients were 
also assured about data confidentiality, safeness of the 
study, and their right of not to participate. We also ob-
served all ethical issues in accordance with the last ver-
sion of the Helsinki Declaration.
3.3. Statistical analysis
Data were analyzed by using SPSS version 16 and descrip-
tive statistics (frequency, and standard deviation) and in-
ferential statistics (test for comparison of KT/V, URR and 
BUN in and membranes and -test for comparison of pre 
and postdialysis BUN in membranes).
The dialysis adequacy was classified into three groups: 
inadequate dialysis (KT/V ≤ 0.89, or URR ≤ 0.60); relatively 
adequate dialysis (KT/V = 0.90 to 1.29 or URR = 0.61 to 0.70); 
and the totally adequate dialysis (KT/V ≥ 1.3, or URR ≥ 0.70). 
Statistical significance was considered at value < 0.05.
4. Results
Most of participants (67.5%) were male with the mean 
of 47.56 ± 10.79 years , 87.5% of the participants used fis-
tula and 12.5% graft for dialysis. of participants were ur-
ban and 15% were living in rural areas. of the participants 
had dialysis history for a period of three to four years. The 
mean of interdialytic weight gain was 1.91 ± 1.07 kg. The 
blood flow rate was between 220-300 /min with a mean 
271 ± 18.91 mL/min. (Table 1).
Table 1. Some Characteristics of Participants
Variables No. (%)
Dialysis history
2 years 10 (25)
3-4 years 16 (40)










Age, y 47.56 ± 10.64 a
Interdialytic weight gain, kg 1.91 (1.07)
Blood flow rate, mL/min 271 (18.91)
Dialysate flow rate, mL/min 500 (10)
a mean ± SD.
Table 2. Comparison of Pre and Post Dialysis BUN in High-Flux and Low-Flux Membranes
Membrane Predialysis BUN a Postdialysis BUN a Paired test P value
Low-Flux 93.90 ± 20.51 36.87 ± 13.16 18.743 0.000
High-Flux 95.32 ± 19.69 32.35 ± 8.83 21.982 0.000
test 0.355 1.859
P value 0.725 0.071
a data are presented as Mean ± SD.
The mean blood urea nitrogen (BUN) before-dialysis 
was 93.90 ± 20.51 mg/dL, which reduced at the end of the 
dialysis to 36.87 ± 13.16 mg/dL. The observed difference 
was statistically significant, (P < 0.001). Furthermore, the 
mean of the BUN before -dialysis was 95.32 ± 19.69 mg/dl, 
which reduced to 32.35 ± 8.83 mg/dL at the end of dialysis 
was statistically significant (P < 0.001) (Table 2).
The mean of BUN before using the -, (93.90 ± 20.51 mg/
dL) and -membrane (95.32 ± 19.69 mg/dL) were not signifi-
cantly different (P = 0.725). Although the mean of BUN af-
ter -dialysis (32.35 ± 8.83 mg/dL) was lower than the mean 
of the BUN after -dialysis (36.87 ± 13.16 mg/dL), this differ-
ence was not statistically significant (P = 0.071) (Table 2).
The URR was 60% to 80% for of the patients in -dialysis; 
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whereas, 70of the patients in -dialysis had the URR 60% 
to 80%. The mean of URR for patients in -dialysis was 0.65 
± 0.14, and in the -dialysis was 0.65 ± 0.09. Although the 
adequacy of dialysis based on URR was higher in the -di-
alysis, the difference was not statistically significant (P = 
0.211) (Table 3).
Table 3. Comparison of URR in High-Flux and Low-Flux membranes a
URR High-Flux Low-Flux
0.40 − 0.59 11 (27.5) 18 (40)
0.60 − 0.79 28 (70) 20 (50)
0.80 − 0.99 1 (2.5) 2 (5)
Mean ± SD 0.65 ± 0.09 0.61 ± 0.14
Paired t-test T = 1.262, P = 0.211
a Data are presented as No. (SD) and mean ± SD.
Table 4. Comparison of KT/V index in High-Flux and Low-Flux membranes a
KT/V High-Flux Low-Flux
0.60 − 0.79 3 (7.5) 6 (15)
0.80 − 0.99 4 (10) 8 (20)
1.0 − 1.19 9 (22.5) 12 (12)
1.20 − 1.39 13 (32.5) 6 (15)
1.40 − 1.59 8 (20) 4 (10)
1.60 − 1.79 1 (2.5) 4 (10)
1.80 − 1.99 1 (2.5) 0 (0)
2.0 − 2.20 1 (2.5) 0 (0)
Mean ± SD 1.27 ± 0.28 1.1 ± 0.32
Paired t-test t = 2.434, P = 0.017
a Data are presented as No. (SD) and mean ± SD.
Table 5. Dialysis Adequacy Based on KT/V and URR in High-Flux and Low-Flux Membranes a
Dialysis Adequacy KT/V URR
High-Flux Low-Flux High-Flux Low-Flux
inadequate 5 (12.5) 9 (22.5) 11 (27.5) 17 (42.5)
insufficient 15 (37.5) 23 (57.5) 19 (47.5) 15 (37.5)
totally adequate 20 (50) 8 (20) 10 (25) 8 (20)
χ² = 9.839, P = 0.043 χ² = 7.180, P = 0.127
a Data are presented as No. (SD).
In dialysis, the most frequent (32.5%) of KT/V was 1.2 to 
1.4 (mean 1.27 ± 0.28); while, in -dialysis the most frequent 
(30%) of KT/V was 1 to 1.2 (mean 1.1 ± 0.32differences was 
statistically significant (P = 0.017) (Table 4 reveal the rela-
tive adequacy of -dialysis.
High-Flux dialysis was totally adequate in 50% of the cas-
es and it was inadequate in 10% of patients based on KT/V. 
The utilization of -dialysis, showed the adequacy only in 
20% of cases and it was inadequate in the other 20%. In 
estimating the adequacy of dialysis based on the URR, in 
-dialysis, 25% of participants had totally adequate dialysis 
and 27.5% had inadequate dialysis. While in the -dialysis 
only % of participants had totally adequate dialysis and 
42.5% had insufficient adequacy of dialysis (Table 5).
5. Discussion
In the present study, the mean adequacy of dialysis by 
using -flux membrane based on KT/V was 1.10 ± 0.32 which 
was still far from the minimum level introduced by the 
Office of Special Disease of the Ministry of Health of Iran 
(KT/V = 1.20). Hojjat investigated the adequacy of dialysis 
in 68 Chronic Renal Failure patients in Jahroom, Iran. His 
findings revealed that the measures of KT/V was less than 
0.8, in 35.29% of patients and URR index was less than 65%, 
in 58.82% of patients which were both less than the mini-
mum level. The mean of dialysis adequacy based on KT/V 
was 0.963 ± 0.757 which revealed an unacceptable dialy-
sis adequacy (23).
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Moslem et al. (2008) investigated the adequacy of dialy-
sis in Ghonabad , Iran. In this research the adequacy of 
both and lux membrane was investigated in two groups 
(each group 15 participants). The mean of KT/V in -group 
was 1.44 ± 0.32 and in 80% of patients the adequacy of di-
alysis was over 1.2 (24).
Although in this study, mean of KT/V in high-dialysis 
was more than our study (in our study 58.4% of patients 
had KT/V ≥ 1.2), and was not statistically different from the 
-dialysis, in our research the adequacy was significantly 
better in -dialysis. In Moslem et al. study, the vascular 
access, blood flow rate, and the type of used membrane 
were not mentioned. Furthermore, the size of the sample 
is relatively smaller than our study.
Ponikvar et al. investigated the comparative efficiency 
of the with lux membranes in acute renal failure in inten-
sive care units. The results showed no statistically signifi-
cant differences in using these two membranes which 
could reveal the inadequacy of -membrane for these pa-
tients (25). This finding may relate to the acute or chronic 
phase of the disease. In chronic status of renal failure due 
to the accumulation of waste materials, the efficiency of 
-membranes would be obvious compared to the -mem-
branes.
El-Wakil et al. investigated the effect of High-Flux ver-
sus Low-Flux hemodialysis on serum , advanced oxida-
tion protein products and protein carbonyl. In the first 
stage, 20 patients were dialyzed by using −membranes 
for a period of weeks. he second phase, were maintained 
on Low-Flux dialysis for same period of 8 weeks. The re-
sults revealed the -was successful in reducing the and 
protein carbonyl. However, the high−membrane did not 
have any observable influence on reducing the advanced 
oxidation protein products. In the same study, however, 
the use of -lux membrane revealed all three indexes were 
significantly increased. The findings confirmed that the 
use of high-lux membrane will significantly better the dif-
fusion of uremic toxins (22). This finding was with our 
study.
Oates et al. investigated the effects of on and the re-
sponses of erythropoietin. Also, they the influence of 
- and -lux membranes in dialysis adequacy. The results 
showed no significant difference between membranes 
(26). But Eknoyan et al. found that -membrane improves 
the adequacy of dialysis in chronic renal failure (27). The 
findings of the present research are with the findings of 
this study.
Makar et al. compared the roles and influences of these 
two membranes on children hemodialysis patients. They 
reported no statistically significant differences in ad-
equacy of these membranes (28). However, in our study 
this difference was significantly important and provided 
supports for the use of -membranes. Markar et al. study 
was conducted with participating children who requires 
certain arrangements such as low blood flow rate, low 
dialysate flow rate and used small diameter membranes 
to make it tolerable for the children. These factors could 
have influences on the adequacy of dialysis.
Santoro et al. investigated the effect of high-flux hemo-
filtration versus low-flux hemodialysis on ortality idney. 
The results revealed that -hemofiltration increased the 
survival and decreased in plasma level significantly (17). 
This study further supports the adequacy of −membrane.
In another study, Mohseni and Ilali investigated the 
adequacy of hemodialysis using bicarbonate dialysate 
in Sari, Iran with 50 participants. The findings revealed 
that the mean of KT/V was 0.92 ± 0.26 and 86% of patients 
had inadequacy of dialysis (KT/V > 1.2). Furthermore, the 
mean of URR was 47.84% and 90% of participants (45 pa-
tients) had URR index less than the minimum standard 
level (65%). of the unacceptable quality of dialysis in most 
patients, they recommended periodical evaluation of the 
quality of dialysis as well as conducting comprehensive 
studies in order to determine viable methods to the ad-
equacy of dialysis (30).
Malekmakan et al. found that only 32.1% of renal failure 
patients achieve the optimal KT/V level and have recom-
mended using advanced dialyzers (31). In our research, 
however, the -group revealed %35 of adequate dialysis of 
KT/V > 1.2 and in -group over 60% of patients had KT/V > 1.2. 
These findings confirm the crucial importance of -mem-
branes in achieving the requirement of optimal dialysis.
Other Iranian research findings revealed inadequacy 
of dialysis in most centers across the country, such as 
the study of Raiesifar et al. (2010) in Abadan using low-
membranes. The mean of KT/V was 0.9 ± 0.21 and the in-
adequacy of dialysis was 97.8 % (32).
Taziki and Kashi reported the inadequacy of dialysis in 
Sar, Iran, by using -membranes and 58% of patients had 
KT/V less than 1 (33). Another study in Birjand, Iran, with 
participation of 50 patients showed that 70% of the pa-
tients had KT/V 0.9 to 1.2, and 66% of patients had URR be-
tween 61% to 70% (30). In our research, in -membrane the 
mean of KT/V was 1.1 ± 0.32 and the ratio of inadequacy 
was 20%, also another 20% of the participants had KT/V 
less than 1, and 55% of them showed URR more than 60%. 
For the -membrane, the mean of KT/V was 1.27 ± 0.28, and 
the inadequacy was seen in 10%, also %17.5 of patients had 
KT/V less than 1, and 72% had URR≥60%. 
The mean of KT/V in studies conducted in the USA and 
Japan was 1.30 ± 0.29 and 1.30 ± 0.2, respectively (31, 32). 
Other studies, revealed that 60% to 80% of patients had 
KT/V equal or more than 1.2 (33). These values were than 
the values in our country as presented in the literature, 
showing the inefficient strategies in Iranian dialysis 
centers. One of the reasons which significantly to the ob-
served efficiency and adequacy of dialysis in developed 
countries, is the more of high-flux membranes; while, in 
our country mostly used low-flux membranes in dialysis 
centers and the patients do not ask for them due to their 
unfamiliarity or carelessness.
Among the other reasons of the low quality of dialysis 
in Iran compared to the developed countries, are the 
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vascular access problems (recirculation), the duration 
of the dialysis session, and the lack of sufficient number 
of dialyzers (30), the blood flow rate, the blood sampling 
method for determining the BUN, insufficient surface of 
the membranes and the type of membranes (12). Suitable 
setting and priming of membranes and hemodialysis set 
and remove the air from them as well as -membranes or 
suitable size could increase the dialysis adequacy.
The use of membranes will improve the adequacy of 
dialysis. Moreover, due to the characteristics of these 
membranes in removing the middle size and large size 
molecules such as , using High-Flux membranes thus al-
lows improved removal of a wider spectrum of uremic 
toxins which may improve the quality of life of patients 
on chronic hemodialysis. According to the result of this 
study, these -membranes in other dialysis centers.
The limitation of study was short followup. It is recom-
mended  comparison of High-Flux and Low-Flux mem-
branes performed in long period (34-36).
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